Cited by 588Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

The DOI matches its Crossref record; 365 of the 371 references it cites were found in a registry or an index.

Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease

Barage, Sagar H., Sonawane, Kailas D.·2015·Neuropeptides

DOI 10.1016/j.npep.2015.06.008

Open this paper in CoChat — free account

Abstract

Alzheimer's disease is an irreversible, progressive neurodegenerative disorder. Various therapeutic approaches are being used to improve the cholinergic neurotransmission, but their role in AD pathogenesis is still unknown. Although, an increase in tau protein concentration in CSF has been described in AD, but several issues remains unclear. Extensive and accurate analysis of CSF could be helpful to define presence of tau proteins in physiological conditions, or released during the progression of neurodegenerative disease. The amyloid cascade hypothesis postulates that the neurodegeneration in AD caused by abnormal accumulation of amyloid beta (Aβ) plaques in various areas of the brain. The amyloid hypothesis has continued to gain support over the last two decades, particularly from genetic studies. Therefore, current research progress in several areas of therapies shall provide an effective treatment to cure this devastating disease. This review critically evaluates general biochemical and physiological functions of Aβ directed therapeutics and their relevance.

Integrity signals

Registry

Crossref · 10.1016/j.npep.2015.06.008

Cites

365 of 365 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y. I., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,716
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Alzheimer’s disease
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569

Flagged first, then by citations

Show all 371 references

6 of the 371 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Kehoe, 2009, 1, 3

Sorted by citations

Items 401–500 of 588

Integrating artificial intelligence with small molecule therapeutics and precision medicine for neurochemical understanding of Alzheimer’s diseases
Alshehri, Z. S. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.055 · Cited by 5
Proteína tau como biomarcador en Alzheimer preclínico
Arriagada, J., & Villalobos, R. A. (2022) · ARS MEDICA Revista de Ciencias Médicas · doi:10.11565/arsmed.v47i2.1892 · Cited by 33
Application of Behavioral Tests for Evaluation of an Experimental Model of Alzheimer’s Disease in Female Rats
Karsuntseva, E. K., Voronova, A. D., Chadin, A. V., Шишкина, В. В., Fursa, G. A., Andretsova, S. S., Reshetov, I. V., Stepanova, O. V., & Chekhonin, V. P. (2023) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-023-05823-0 · Cited by 5
Low Levels of Amyloid Precursor Protein (APP) Promote Neurogenesis and Decrease Gliogenesis in Human Neural Stem Cells
Coronel, R., López-Alonso, V., Gallego, M. I., & Liste, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914635 · Cited by 5
Role of Amyloid Beta in Neurodegeneration and Therapeutic Strategies for Neuroprotection
Ghosh, P., Narang, K., & Iyer, P. K. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3662-6_25 · Cited by 5
A closer look at pathogenic amyloid-β in Alzheimer’s disease using cryo-electron microscopy: a narrative review
Gao, Y., Schedin‐Weiss, S., & Tjernberg, L. O. (2024) · Advanced technology in neuroscience . · doi:10.4103/atn.atn-d-24-00014 · Cited by 5
The Role of Inflammation in Amyloid Diseases
Azevedo, E. P., & Foguel, D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81888 · Cited by 7
Effects of Gentiana delavayi Flower Extract on APP Processing in APP/PS1 CHO Cells
Yang, M., Zhou, K., Li, F., Yang, H., Yin, M., Zhang, L.-H., & Wang, F. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00720 · Cited by 5
Association Between Antibiotic Treatment of Leptospirosis Infections and Reduced Risk of Dementia: A Nationwide, Cohort Study in Taiwan
Chao, P.-C., Chien, W., Chung, C., Huang, C.-K., Li, H.-M., & Tzeng, N. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.771486 · Cited by 5
Quantum dots-based “chemical tongue” for the discrimination of short-length Aβ peptides
Głowacz, K., Drozd, M., Tokarska, W., Wezynfeld, N. E., & Ciosek, P. (2024) · Microchimica Acta · doi:10.1007/s00604-023-06115-0 · Cited by 5
Biotransformation of 1α,11α-dihydroxyisopimara-8(14),15-diene by Cunninghamella echinulata NRRL 1386 and their neuroprotective activity
Chokchaisiri, R., Chaichompoo, W., Pabuprapap, W., Sukcharoen, O., Tocharus, J., Ganranoo, L., Bureekaew, S., Sangvichien, E., & Suksamrarn, A. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104799 · Cited by 5
Age-Related Neurodegenerative Diseases: An Update
Rivero-Segura, N. A., Guerrero-Cruz, A. A., & Barrera-Vázquez, O. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_2 · Cited by 5
The Therapeutic Potential of Dalbergia pinnata (Lour.) Prain Essential Oil in Alzheimer’s Disease: EEG Signal Analysis In Vivo, SH-SY5Y Cell Model In Vitro, and Network Pharmacology
Qin, S., Fang, J., He, X., Yu, G., Yi, F., & Zhu, G. (2024) · Biology · doi:10.3390/biology13070544 · Cited by 4
Suppression of amyloid-β fibril growth by drug-engineered polymorph transformation
Mafimoghaddam, S., Xu, Y., Sherman, M. B., Orlova, E. V., Karki, P., Orman, M. A., & Vekilov, P. G. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102662 · Cited by 4
Roles of nano medicine in diagnosis of Alzheimer's disease
Kaushal, M. A., Patel, N., Xavier, G., & Prajapati, B. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00017-0 · Cited by 4
The Different Molecular Targets and Its Significant Role in Alzheimer’s Disease: A Review
Perumal, D. P., & Pichaivel, M. (2024) · Asian Journal of Medicine and Biomedicine · doi:10.37231/ajmb.2024.8.1.650 · Cited by 4
Combination of tenuigenin-based Polygala tenuifolia willd. root extract and forsythoside a improved Alzheimer’s disease
Liang, G., Gao, C., Zhang, L., & Du, H. (2024) · Natural Product Research · doi:10.1080/14786419.2024.2332945 · Cited by 4
Cognition and Oral Health: Association Between Alzheimer's Disease and Periodontitis
Park, S., Yoon, J. W., & Park, W. (2024) · Psychiatric Annals · doi:10.3928/00485713-20240722-01 · Cited by 4
Evaluation of metabolite profiles and neuroprotective potential in four pomegranate cultivars for Alzheimer's disease prevention
Lee, H., Chater, J. M., Heinitz, C. C., & Wang, Y. (2025) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.14176 · Cited by 4
Crosstalk between NLRP3 inflammasome and calpain in Alzheimer's disease
Mamsa, R., Prabhavalkar, K. S., & Bhatt, L. K. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16139 · Cited by 4
Pharmacokinetics, bioavailability and tissue distribution study of JCC-02, a novel N-methyl-d-aspartate (NMDA) receptor inhibitor, in rats by LC-MS/MS
Yang, T., Shi, Y. X., Lin, C., Yan, C., Zhang, D., & Lin, J. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.02.018 · Cited by 4
Essential Oils as Effective Agents Against Neurological Disorders
Pai, S. R., Sonkamble, V. V., & Wagh, N. S. (2020) · Springer eBooks · doi:10.1007/978-981-15-1761-7_17 · Cited by 4
Dementia and cognitive decline
Huq, A. J., Eratne, D., & Velakoulis, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99417-0.00006-9 · Cited by 4
Advanced Nanopharmaceutical Intervention for the Reduction of Inflammatory Responses and the Enhancement of Behavioral Outcomes in APP/PS1 Transgenic Mouse Models
Li, J., Huang, D., Liao, W., Wang, Y., Liu, Y., & Luan, P. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020177 · Cited by 3
Biochanin-A: A Potential Candidate for the Treatment of Alzheimer’s Disease
Singh, N. K., & Bhushan, B. (2025) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010362795250223160707 · Cited by 3
Nigella sativa oil attenuates neuroinflammation and cognitive deficits in a rat model of Alzheimer's disease
Arslan, S. O., Uysal, F., Koç, A., & Çam, S. A. (2025) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1588353 · Cited by 3
Color Dependence of OLED Phototherapy for Cognitive Function and Beta-Amyloid Reduction through ADAM17 and BACE1
Noh, B., Lee, H.-J., Lee, J., Lee, J., Joo, B., Jung, Y., Park, M., Kang, S., Oh, S., Hwang, J.-W., et al. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01162 · Cited by 3
Neuro-protection of swertisin against impairment induced by Aβ25-35 by acting on COX-2 to up-regulate 2-AG and suppressing neuroinflammation
Wu, J., Zhou, L., & Lang, C. (2025) · Neuroscience Letters · doi:10.1016/j.neulet.2025.138429 · Cited by 3
Phosphorylation and Dephosphorylation of Beta-Amyloid Peptide in Model Cell Cultures: The Role of Cellular Protein Kinases and Phosphatases
Barykin, E. P., Yanvarev, D. V., Strelkova, M. A., Треворович, В.-Э. В., Varshavskaya, K. B., Mitkevich, V. A., & Makarov, A. А. (2023) · Life · doi:10.3390/life13010147 · Cited by 3
N-3 polyunsaturated fatty acids attenuate amyloid-beta-induced toxicity in AD transgenic Caenorhabditis elegans via promotion of proteasomal activity and activation of PPAR-gamma
Wang, Y., Zhang, H., Ding, F., Li, J., Li, L., Xu, Z., & Zhao, Y. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109603 · Cited by 5
Serum and urine metabolomics based on UPLC–QTOF/MS reveal the effect and potential mechanism of “schisandra–evodia” herb pair in the treatment of Alzheimer's disease
Pang, C., Wang, R., Liu, K., Xu, Y., Ni, J., Cao, Q., Chen, Y., Dong, P., & Han, H. (2024) · Biomedical Chromatography · doi:10.1002/bmc.5882 · Cited by 3
Nodal degree centrality in the default mode-like network of the TgF344-AD Alzheimer’s disease rat model as a measure of early network alterations
Amiri, S., van den Berg, M., Nazem-Zadeh, M.-R., Verhoye, M., Amiri, M., & Keliris, G. A. (2024) · npj Aging · doi:10.1038/s41514-024-00151-7 · Cited by 3
Anti-inflammatory and antioxidant effects of fenugreek in preventing mice model of Alzheimer's disease
Xiong, L., Li, Q., Zhou, X., Xiao, J., Yang, X., Xu, H., & Guo, C. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241312970 · Cited by 3
Reevaluating Alzheimer’s disease treatment: Can phytochemicals bridge the therapeutic Gap?
Roy, K. K., Mehta, D. K., & Das, R. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.04.014 · Cited by 3
Effects of coconut oil on Alzheimer disease
ALMatrafi, T. A. (2021) · International Journal of ADVANCED AND APPLIED SCIENCES · doi:10.21833/ijaas.2021.05.013 · Cited by 3
Down syndrome and Alzheimer’s disease: Same infectious cause, same preventive?
Norins, L. C. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110745 · Cited by 3
The Molecular and Functional Changes of Neural Stem Cells in Alzheimer’s Disease: Can They be Reinvigorated to Conduct Neurogenesis
Abu‐El‐Rub, E., Khasawneh, R. R., Almahasneh, F. A., Aloud, B. M., & Zegallai, H. M. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220831105257 · Cited by 3
The 3-(3-oxoisoindolin-1-yl)pentane-2,4-dione (ISOAC1) as a new molecule able to inhibit Amyloid β aggregation and neurotoxicity
Piccialli, I., Greco, F., Roviello, G. N., Sisalli, M. J., Tedeschi, V., Mola, A. D., Borbone, N., Oliviero, G., Feo, V. D., Secondo, A., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115745 · Cited by 3
Kolinesteraz İnhibitörlerinin Alzheimer Hastalığı Tedavisindeki Rolü
Kurban, M. G., & Şentürk, M. (2024) · Ağrı Tıp Fakültesi Dergisi · doi:10.61845/agrimedical.1375889 · Cited by 3
The Impact of Shift Work on Nurses' well-being and Patient Care Excellence in Inpatient Settings
Mober, S. M. A., Mohemmed, M. A., Khrizi, R. M. A., Dabaa, H. Y. M., Zayed, T. H. A., Tayeb, H. J. T., Bajaafer, N. H. H., & Kariri, F. N. A. (2024) · British Journal of Nursing Studies · doi:10.32996/bjns.2024.4.2.11 · Cited by 3
Inhibition of the Transforming Growth Factor‐β Signaling Pathway Confers Neuroprotective Effects on Beta‐Amyloid‐Induced Direct Neurotoxicity and Microglia‐Mediated Neuroinflammation
Tiong, S. Q., Mohgan, R., Quek, J. Y., Liew, J. Y. S., Wong, G. Y. S., Thang, Z. Q., Chan, Z. L., Gan, S. Y., & Chan, E. W. L. (2025) · Neurology Research International · doi:10.1155/nri/8948290 · Cited by 3
Exploring pyridinium-based inhibitors of cholinesterases: A review of synthesis, efficacy, and structural insights
Polo-Cuadrado, E., Rojas-Peña, C., Acosta-Quiroga, K., Camargo-Ayala, L., Rodríguez‐Núñez, Y. A., Osorio, E. H., López, J. J., Rhonny, B.-C., & Gutiérrez, M. (2025) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2025.100270 · Cited by 3
Lead discovery of a guanidinyl tryptophan derivative on amyloid cascade inhibition
Suwattananuruk, P., Jiaranaikulwanitch, J., Waiwut, P., & Vajragupta, O. (2020) · Open Chemistry · doi:10.1515/chem-2020-0067 · Cited by 3
Nanoneuromedicines for Neurodegenerative Diseases
Singh, R., & Geetanjali, G. (2017) · Nanoscience & Nanotechnology-Asia · doi:10.2174/2210681208666171211160433 · Cited by 3
Electrochemical Detection of Isoform‐Specific Interaction between Apolipoprotein E and Amyloid‐β
Su, H., Jin, Y., Noroozifar, M., & Kerman, K. (2018) · ChemElectroChem · doi:10.1002/celc.201800985 · Cited by 3
Risk of Dementia in Patients with Leptospirosis: A Nationwide Cohort Analysis
Chiu, C.-H., Chen, P.-C., Wang, Y.-C., Lin, C., Lee, F.-Y., Wu, C., & Chang, K. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16173168 · Cited by 3
Possible Link between Porphyromonas gingivalis and Amyloidosis in the Pathogenesis of Alzheimer’s and Parkinson’s Disease.
(2020) · doi:10.46940/ijpi.01.1001 · Cited by 3
Network Analysis and Molecular Mapping for Alzheimer’s Disease to Reveal the Drug Targets of ArbutinPreprint
Uvarajan, D., Ravikumar, M., & Durairaj, B. (2023) · Research Square · doi:10.21203/rs.3.rs-3474607/v1 · Cited by 3
Effect of Nigella sativa L. extract on improving memory function through reducing GSK3β activation and Aβ42/40 ratio
Andriana, K., Nurdiana, N., Barlıanto, W., Wıyasa, I. W. A., & Rahayu, M. (2022) · Journal of Pharmacy & Pharmacognosy Research · doi:10.56499/jppres21.1211_10.2.328 · Cited by 2
Potential role of dietary whole grains in Alzheimer's disease: bioactive components, mechanistic insights, and epidemiological evidence
Shen, M., Yu, X., Wu, S., Qiu, J., Wang, R., Li, K., & Zhang, Q. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.105182 · Cited by 3
Computer-aided Drug Design for Alzheimer's Disease: Recent Advancements and Future Perspectives
Rohilla, S., & Goyal, G. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266343814250713100224 · Cited by 2
Decoding the Gut-Brain Axis in Alzheimer’s Disease: Emerging Perspectives
Singh, V., Yadav, A., Taj, T., Islam, A., Mantry, S., Debnath, B., Kumar, B., & Ashique, S. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273390442250805174841 · Cited by 2
Exploring Alzheimer’s diseases with focus on diagnostic strategies targeting amyloid beta 42 (Aβ42)
Chauhan, A., Devi, R., Singh, S., Bhutani, K., Prasad, S., Singh, A., Bhaskar, N., Kumar, S., Saini, A. K., & Thakur, R. (2025) · Discover Neuroscience · doi:10.1186/s13064-025-00217-6 · Cited by 5
Targeting Alzheimer's disease via phytochemicals from Artemisia campestris L.: GC/MS analysis with an integrated computational approach
Zouaghi, N., Lanez, E., Benamor, M. L., Nacer, S. N., Lanez, T., Bekkar, Y., Haddad, H., Al-Abdallat, K., Zihlif, M., Al-Abdallat, Y., et al. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.108128 · Cited by 2
Effects of Single Amino Acid Substitutions on Aggregation and Cytotoxicity Properties of Amyloid β Peptide
Estrada-Rodríguez, A. E., Valdez‐Pérez, D., Ruiz-Garcia, J., Treviño-Garza, A., Gómez-Martínez, A. M., Martı́nez-Rodrı́guez, H. G., Rivas-Estilla, A. M., Vidaltamayo, R., & Zomosa‐Signoret, V. (2018) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-018-9693-x · Cited by 2
Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-β-Induced Alzheimer’s Disease Model
Paulo, S. L., Ribeiro‐Rodrigues, L., Rodrigues, R. S., Mateus, J. M., Fonseca‐Gomes, J., Soares, R., Diógenes, M. J., Solá, S., Sebastião, A. M., Ribeiro, F. F., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201567 · Cited by 2
Interplays between different secretases in the generation of Amyloid- β lead to the emergence of ‘Amyloid- β rise’
Zhang, Y., Li, B.-L., & Sun, G. (2023) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2023.113875 · Cited by 2
CGAs-Rich Conilon Coffee Consumption Improves Cognition and Reduces Oxidative Stress in Elderly with Alzheimer’s Disease: A Pilot Study
Boschetti, J. C. L., Soares, K. L., Carvalho, G. R., Filho, A. C. V., Ton, A. M. M., Pereira, T. D. M. C., & Scherer, R. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230843 · Cited by 2
Characterizing fibril morphological changes by spirooxindoles for neurodegenerative disease application
Dahdah, A., de Silva, N. H., Maniam, S., & Blanch, E. W. (2024) · The Analyst · doi:10.1039/d3an01773g · Cited by 2
Liquid clues: tear film biomarkers unravelling Alzheimer’s mysteries
Zaheer, A., Anwar, I. B., Haseeb, A., & Yadav, A. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002014 · Cited by 2
Rhei Undulati Rhizoma attenuates memory decline and reduces amyloid-β induced neuritic dystrophy in 5xFAD mouse
Lee, S., Ju, I. G., Eo, H., Kim, J. H., Choi, Y., & Oh, M. S. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00966-2 · Cited by 3
Concurrent Alzheimer's disease pathologies in Lewy body diseases affect cognition and glucose metabolism in the posterior cingulate gyrus: A multimodal PET study
Nakamura, K., Tagai, K., Shinotoh, H., Hirano, S., Kitamura, S., Endo, H., Takahata, K., Takado, Y., Zhang, M., Kawamura, K., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251351220 · Cited by 2
Evaluating digital device technology in Alzheimer’s disease via artificial intelligence
Sood, M., Aborageh, M., Domingo‐Fernándéz, D., Harms, R., Lordick, T., Birkenbihl, C., Owens, A. P., Coello, N., Narayan, V. A., Aarsland, D., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.053574 · Cited by 3
Neural Regeneration as a Disease-Modifying Therapeutic Strategy for Alzheimer’s Disease
Kazim, S. F., & Iqbal, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00002-8 · Cited by 2
Therapeutic Potential of PPARs in Alzheimer’s Disease
Upaganlawar, A. B., Upasani, C. D., & Ihim, S. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_14 · Cited by 2
Hydroxysafflor Yellow A Exerts Neuroprotective Effect by Reducing Aβ Toxicity Through Inhibiting Endoplasmic Reticulum Stress in Oxygen–Glucose Deprivation/Reperfusion Cell Model
Ma, H., Wen, J., Fang, H., Su, S., Wan, C., Zhang, C., Lu, F.-M., Fan, L.-L., Wu, G., Zhou, Z., et al. (2023) · Rejuvenation Research · doi:10.1089/rej.2022.0054 · Cited by 2
Binding mechanism of full-length Aβ40 peptide to a mixed lipid bilayer
Wang, K., & Cai, W. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2024.1367793 · Cited by 2
Early sensory deficits in Alzheimer’s disease: A review of potential integrating diagnostic methods
Yang, Y. (2024) · Journal of Clinical and Translational Science · doi:10.1017/cts.2024.525 · Cited by 2
Unique Inversion Events of Residues around the Backbone in the Turn Domain of β-Arches in Amylin Fibrils
Atsmon‐Raz, Y., Wineman‐Fisher, V., Baram, M., & Miller, Y. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00554 · Cited by 2
Synthesis of 1-Hydroxy-3-O-Substituted Xanthone Derivatives and their Structure-activity Relationship on Acetylcholinesterase Inhibitory EffectPreprint
Vanessa, V. V., Teh, S. S., Lam, K. W., & Mah, S. H. (2021) · Research Square · doi:10.21203/rs.3.rs-763326/v1 · Cited by 2
Monoclonal antibody therapy in Alzheimer’s disease: an overview and vision
Bentley, J. H., Bishop, L. E., & Broussard, J. I. (2024) · Brain Network and Modulation · doi:10.4103/bnm.bnm_14_23 · Cited by 2
Electrochemical Fingerprinting for Discrimination of $\mathrm{A}\beta_{3-16}, \mathrm{A}\beta_{11-16}$ and their Pyroglutamate Counterparts, Related to Alzheimer's Disease
Tobolska, A., Biernat, K., Wezynfeld, N. E., Wróblewski, W., & Ciosek, P. (2024) · Proceedings of IEEE Sensors/Proceedings of IEEE Sensors ... · doi:10.1109/sensors60989.2024.10784537 · Cited by 1
Advancing Alzheimer’s Diagnosis: The Role of AI - A Review
Rehan, D., Solisch, S., Blazhkova, A., Susłow, A., Szwed, A., & Szczęsna, E. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.77.57093 · Cited by 2
Dual‐Functional Synthetic Linear and Cyclic Peptides with Anti‐Amyloid and Antimicrobial Activities for Alzheimer's Disease
Yang, L., Wang, Y., Shang, P., & Ma, G. (2025) · Chemistry - A European Journal · doi:10.1002/chem.202404349 · Cited by 1
Neuroprotective Effects of Phosphodiesterase Inhibitors on Sestrin-2 (SESN2) Expression and Autophagy in Alzheimer’s Disease Model
Faikoğlu, G., Saygisever-Faikoglu, K., Özbaşak, H., Ugur, S. A., Uskur, T., Akkan, A. G., Kelicen‐Uğur, P., & Özyazgan, S. (2025) · Cureus · doi:10.7759/cureus.88449 · Cited by 1
Polymyxin-B as a novel inhibitor of amyloid beta aggregation: Computational insights and experimental validation
Mohammed, A. A., Barale, S. S., Dhotare, P. S., & Sonawane, K. D. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.143738 · Cited by 1
Self-citation
Green synthesis of lemon peel-derived multifunctional carbon dots for Alzheimer's disease with activities of alleviating oxidative stress, inhibiting AChE and Aβ aggregation
Zhu, W.-L., Meng, L., & Shen, L. (2026) · Chemical Physics Letters · doi:10.1016/j.cplett.2026.142910 · Cited by 1
Progress in (Photo)electrochemical Biosensors for the Detection of Amyloid-Beta Oligomer
Huang, Y., Wang, N., Yi, X., & Xia, N. (2026) · Biosensors · doi:10.3390/bios16060349 · Cited by 1
Novel Somatostatin Receptor Subtype‐4 Agonist Mitigates Microglia Inflammatory Activation
Silwal, A., Mobayen, S., Crider, A. M., Neumann, W. L., House, A., Umbaugh, D. S., Bhandari, S., Sandoval, K. E., & WITT, K. A. (2019) · The FASEB Journal · doi:10.1096/fasebj.2019.33.1_supplement.501.3 · Cited by 1
[Benefits for the nation: population health care].
Barajas, E. R. (2012) · PubMed · Cited by 1
The alteration of neurogenesis and pathological markers in alzheimer’s disease after deep brain stimulation
Nassehi, B., Kocabıçak, E., Temel, Y., & Hescham, S. (2021) · Turkish Neurosurgery · doi:10.5137/1019-5149.jtn.35598-21.2 · Cited by 1
Alzheimer’s disease: Causes, treatment & basic science review
Sharma, S. (2021) · IP International Journal of Comprehensive and Advanced Pharmacology · doi:10.18231/j.ijcaap.2021.020 · Cited by 1
Agarwood (Aquilaria crassna) Inhibits Beta-amyloid and Tau-protein Formation in a Mouse Obesity Model
Jang, H.-M., Kim, J.-H., Park, G., Choi, Y. D., Kim, S.-E., & Jeon, G. J. (2022) · Journal of Animal Health and Production · doi:10.17582/journal.jahp/2022/10.2.221.225 · Cited by 1
Novel Pharmacological Approach to the Treatment of Alzheimer’s Disease
-, M. S. D., & -, P. T. J. (2022) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2022.v04i06.1069 · Cited by 1
Weakly supervised learning analysis of Aβ plaque distribution in the whole rat brain
Chen, Z., Zheng, W., Pang, K., Xia, D., Guo, L., Chen, X., Wu, F., & Wang, H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1097019 · Cited by 1
The Role of Mesenchymal Stem Cell Exosomes in the Onset and Progression of Alzheimer's Disease
Tian, M., & Yi, X. (2024) · Biomedical Sciences · doi:10.11648/j.bs.20241001.12 · Cited by 1
Recent Advances in Understanding and Managing Alzheimer's Disease: from Pathogenesis to Treatment
Cavalcante, R. L. D. C., Samartino, M., Miranda, L. A., Mendes, J. D. S. A., Tanaka, T. D. L., Silva, F., Molina, L. M., Diniz, B. C., Dantas, D. A., Sarges, D. A. F., et al. (2024) · Revista de Gestão Social e Ambiental · doi:10.24857/rgsa.v18n1-176 · Cited by 1
Advances in Alzheimer's disease and its treatment
Qian, S. (2024) · Highlights in Science Engineering and Technology · doi:10.54097/xr368202 · Cited by 2
Impact of multiple infections on risk of incident dementia according to subjective cognitive decline status: a nationwide population-based cohort study
Lee, J.-W., Kim, M., Kim, H., Kim, S., Um, Y. H., Wang, S., Lim, H. K., Lee, C. U., & Kang, D. W. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1410185 · Cited by 2
Fisiopatologia da doença de Alzheimer e o uso dos principais biomarcadores para o diagnóstico precoce
Leite, J. R. S., de Medeiros, A. B. M., Diniz, L. A. S., Lima, C. S., de Oliveira, L. N. L., Jesus, N. A. D. S., Leonel, J. S., Quaresma, L. D. J. V., Costa, J., Benício, J. A., et al. (2025) · Caderno Pedagógico · doi:10.54033/cadpedv22n1-038 · Cited by 1
The pathophysiological signaling and efficacy of medicinal herbal compounds in Alzheimer’s disease
Darabi, S., Ariaei, A., Gorgich, E. A. C., Rezaei, S., Behruzi, M., Abasian, Z., & Rustamzadeh, A. (2025) · Physiology and Pharmacology · doi:10.61186/phypha.29.1.3 · Cited by 1
Cognitive Guardians: Exploring Flavonoids as Potential Therapeutic Agents in Alzheimer’s Disease Treatment
Gohil, K. J. (2023) · Psychology and Mental Health Care · doi:10.31579/2637-8892/234 · Cited by 1
Novel BODIPY-Based Fluorescent Probes with Improved Aqueous Solubility for Selective Detection of Soluble Aβ Aggregates
Akasaka, T., Watanabe, H., & Ono, M. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00525 · Cited by 1
Neuropsychiatric Symptoms Related to Cholinergic Deficits in Parkinson’s Disease
Perez‐Lloret, S., Peralta, M. C., & Barrantes, F. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-53126-7_27 · Cited by 1
Tocotrienols: Mother Nature’s Gift to the Brain
Musa, A. F., Min, C. J., & Yap, C. G. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-6467-0_5 · Cited by 1
Molecular details of aluminium-amyloid β peptide interaction by nuclear magnetic resonance
Petersingham, G., Zaman, M. S., Johnson, A. J., Reddy, N., Torres, A. M., & Wu, M. J. (2022) · BioMetals · doi:10.1007/s10534-022-00399-0 · Cited by 1
BMP9 ameliorates amyloid pathology by promoting low-density lipoprotein receptor-related protein 1 expression in APP/PS1 transgenic mice
Xiong, L., & Wang, Z. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137159 · Cited by 1
Synaptic modifications in hippocampal CA3 pyramidal cells in an Alzheimer's mouse model
Zhang, P. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6752 · Cited by 1
Evaluation of BACE1 silencing as a therapy against Alzheimer disease: implications for lipid metabolism and inflammatory response
Villamil-Ortiz, J. G. (2019) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.99684546 · Cited by 1
MAPK/ERK Dysfunction in Neurodegenerative DiseasesPreprint
Albert‐Gascó, H., Ros‐Bernal, F., Castillo-Gómez, E., & Olucha-Bordonau, F. E. (2020) · doi:10.32545/encyclopedia202007.0001.v3 · Cited by 1

Authors: Barage, S. H., & Sonawane, K. D.
Affiliations: Shivaji University (IN)
Corresponding author: Sonawane, Kailas D.
ORCID: Barage, Sagar H.
Sonawane, Kailas D.
Venue: Neuropeptides
Publisher: Elsevier BV
Published: 2015-08
Volume: 52
Pages: 1-18
ISSN: 0143-4179 (ISSN-L)
DOI: 10.1016/j.npep.2015.06.008
OpenAlex: W2099751992
Cited by: 579
References: 371
Citations by year: 2026: 22 · 2025: 57 · 2024: 75 · 2023: 69 · 2022: 58 · 2021: 67 · 2020: 59 · 2019: 58 · 2018: 51 · 2017: 33 · 2016: 24 · 2015: 5
FWCI: 4.66
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuropeptides (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords: Alzheimer's disease, amyloid hypothesis, amyloid-beta, amyloid plaques, tau protein, cerebrospinal fluid biomarkers, cholinergic neurotransmission, neurodegeneration, Alzheimer's disease therapeutics, genetic risk factors
MeSH terms: Acetylcholine, Alzheimer Disease, Animals, Brain, Humans, Signal Transduction, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Neurofibrillary Tangles, tau Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks